Kevin A. Lobo
Net Worth

Last updated:

What is Kevin A. Lobo net worth?

The estimated net worth of Mr. Kevin A. Lobo is at least $117,890,158 as of 7 Nov 2024. He owns shares worth $39,004,528 as insider, has earned $43,245,630 from insider trading and has received compensation worth at least $35,640,000 in Stryker Corporation.

What is the salary of Kevin A. Lobo?

Mr. Kevin A. Lobo salary is $2,970,000 per year as Chairman, Chief Executive Officer & Pres in Stryker Corporation.

How old is Kevin A. Lobo?

Mr. Kevin A. Lobo is 60 years old, born in 1965.

What stocks does Kevin A. Lobo currently own?

As insider, Mr. Kevin A. Lobo owns shares in one company:

Company Title Shares Price per share Total value
Stryker Corporation (SYK) Chairman, Chief Executive Officer & Pres 100,027 $389.94 $39,004,528

What does Stryker Corporation do?

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.

Kevin A. Lobo insider trading

Stryker Corporation

Mr. Kevin A. Lobo has made 14 insider trades between 2013-2024, according to the Form 4 filled with the SEC. Most recently he sold 23,178 units of SYK stock worth $8,542,947 on 7 Nov 2024.

The largest trade he's ever made was exercising 187,470 units of SYK stock on 2 Dec 2022. As of 7 Nov 2024 he still owns at least 100,027 units of SYK stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 23,178 $368.58 $8,542,947
Option
Common Stock 156,890 $93.06 $14,600,183
Sale
Common Stock 15,866 $369.75 $5,866,454
Option
Employee Stock Option granted 2/11/2015 (right to buy) 156,890 $93.06 $14,600,183
Sale
Common Stock 18,269 $367.95 $6,722,079
Option
Common Stock 905 N/A N/A
Option
Dividend Equivalents 905 N/A N/A
Option
Common Stock 504 N/A N/A
Option
Dividend Equivalents 504 N/A N/A
Sale
Common Stock 23,423 $240.16 $5,625,268
Option
Common Stock 187,470 $64.01 $11,999,955
Sale
Common Stock 43,809 $239.43 $10,489,014
Option
Employee Stock Option granted 02/13/2013 (right to buy) 187,470 $64.01 $11,999,955
Option
2019 Performance Stock Units 33,925 N/A N/A
Option
Common Stock 33,925 N/A N/A
Sale
Common Stock 107,795 $55.66 $5,999,870
Option
Employee Stock Option granted 10/01/2012 (right to buy) 107,795 $55.66 $5,999,870
Option
Common Stock 107,795 $55.66 $5,999,870
Sale
Common Stock 10,697 N/A N/A
Option
Employee Stock Option granted 02/21/2012 (right to buy) 27,985 $53.6 $1,499,996
Option
Common Stock 27,985 N/A N/A
Sale
Common Stock 25,855 N/A N/A
Option
Employee Stock Option granted 04/26/2011 (right to buy) 25,855 $58.02 $1,500,107
Option
Common Stock 25,855 $58.02 $1,500,107
Sale
Common Stock 19,286 N/A N/A
Sale
Common Stock 41,750 N/A N/A
Sale
Common Stock 39,808 N/A N/A
Sale
Common Stock 9,539 N/A N/A
Sale
Common Stock 26,306 N/A N/A
Sale
Common Stock 25,952 N/A N/A
Option
Restricted Stock Units granted 10/01/2012 53,899 N/A N/A
Option
Common Stock 53,899 N/A N/A
Option
Common Stock 6,000 N/A N/A
Option
Restricted Stock Units granted 02/21/2012 6,000 N/A N/A
Option
Common Stock 8,618 N/A N/A
Option
Restricted Stock Units granted 04/26/11 8,618 N/A N/A
Option
Common Stock 3,000 N/A N/A
Option
Restricted Stock Units granted 02/21/2012 3,000 N/A N/A
Option
Common Stock 3,000 N/A N/A
Option
Restricted Stock Units granted 02/21/2012 3,000 N/A N/A